Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
Skip Navigation LinksCVMBS Home > Veterinary Teaching Hospital > For Veterinarians > Clinical Trials > Evaluation of a Novel Therapeutic in the Treatment of Canine Parvovirus
Evaluation of a Novel Therapeutic in the Treatment of Canine Parvovirus

Return to the Clinical Trials Homepage.

Who qualifies?

Puppies diagnosed with canine parvovirus, based on ELISA snap test. The puppy must weigh more than 1.5 kg (approximately three pounds), less than 6 months of age, displaying clinical signs consistent with parvovirus infection (anorexia, vomiting, diarrhea), and have never been vaccinated for parvo. The puppy must not have received any treatment for parvo prior to study enrollment.

Purpose of the study

Canine parvovirus (or parvo) is often a deadly disease unless puppies are hospitalized with aggressive supportive care. Hospitalization can become cost-prohibitive, therefore new treatments that may shorten the course of disease or clinical severity, are needed. The purpose of this study is to investigate a novel biologic product that may aid in the recovery of puppies affected with parvo. Puppies will receive standard-of-care treatment for parvo which includes IV fluids, antibiotics and anti-nausea medication. Additionally, puppies may receive an additional treatment (a novel biologic product) that may hasten the recovery from parvo. This is a randomized study, meaning some puppies will receive the biologic product and some puppies will receive a placebo.


Owners must be willing to hospitalize their puppy until he/she has recovered from parvo and is ready to go home. All costs of hospitalization will be paid for by the study, but owners are required to pay the $125 examination fee, as well as the cost for the ELISA snap test (approximately $30).

After hospital dismissal, owners must be willing to bring their puppy back  at 30-days and 90-days. This is to perform some follow-up tests that will be at no charge to the owner.


All costs associated with hospitalization and treatment of parvo will be covered by the study.

To Enroll

Call 970-297-5000 if you have a puppy that meets the above criteria. Non-emergent questions can be emailed to Dr. Lauren Sullivan.